Perigon Wealth Management LLC Has $476,000 Position in HCA Healthcare, Inc. (NYSE:HCA)

Perigon Wealth Management LLC boosted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,759 shares of the company’s stock after purchasing an additional 44 shares during the period. Perigon Wealth Management LLC’s holdings in HCA Healthcare were worth $476,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Wedmont Private Capital raised its position in HCA Healthcare by 1.6% in the 4th quarter. Wedmont Private Capital now owns 2,527 shares of the company’s stock valued at $711,000 after purchasing an additional 39 shares during the last quarter. Creative Financial Designs Inc. ADV raised its stake in shares of HCA Healthcare by 19.9% in the fourth quarter. Creative Financial Designs Inc. ADV now owns 253 shares of the company’s stock worth $68,000 after acquiring an additional 42 shares during the last quarter. Huntington National Bank grew its stake in shares of HCA Healthcare by 0.4% during the third quarter. Huntington National Bank now owns 11,206 shares of the company’s stock valued at $2,756,000 after purchasing an additional 44 shares during the last quarter. Brookstone Capital Management lifted its holdings in HCA Healthcare by 1.1% during the 4th quarter. Brookstone Capital Management now owns 4,569 shares of the company’s stock worth $1,237,000 after buying an additional 49 shares in the last quarter. Finally, UMB Bank n.a. raised its position in shares of HCA Healthcare by 5.9% during the third quarter. UMB Bank n.a. now owns 904 shares of the company’s stock worth $222,000 after acquiring an additional 50 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Kathryn A. Torres sold 3,861 shares of the business’s stock in a transaction that occurred on Wednesday, January 31st. The stock was sold at an average price of $307.00, for a total transaction of $1,185,327.00. Following the completion of the sale, the senior vice president now owns 15,899 shares in the company, valued at $4,880,993. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In other HCA Healthcare news, SVP Kathryn A. Torres sold 3,861 shares of the company’s stock in a transaction on Wednesday, January 31st. The stock was sold at an average price of $307.00, for a total value of $1,185,327.00. Following the transaction, the senior vice president now directly owns 15,899 shares of the company’s stock, valued at approximately $4,880,993. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Michael S. Cuffe sold 3,200 shares of the company’s stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $306.79, for a total transaction of $981,728.00. Following the completion of the transaction, the executive vice president now owns 24,929 shares in the company, valued at $7,647,967.91. The disclosure for this sale can be found here. Insiders have sold a total of 14,840 shares of company stock worth $4,588,869 over the last ninety days. Insiders own 1.70% of the company’s stock.

HCA Healthcare Trading Down 0.1 %

HCA Healthcare stock opened at $322.54 on Tuesday. The firm has a 50-day moving average of $320.01 and a 200-day moving average of $280.13. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $335.83. The company has a debt-to-equity ratio of 35.07, a current ratio of 1.18 and a quick ratio of 1.02. The company has a market cap of $85.31 billion, a price-to-earnings ratio of 16.99, a P/E/G ratio of 1.62 and a beta of 1.65.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, January 30th. The company reported $5.90 EPS for the quarter, beating the consensus estimate of $5.05 by $0.85. The company had revenue of $17.30 billion during the quarter, compared to the consensus estimate of $16.51 billion. HCA Healthcare had a return on equity of 996.30% and a net margin of 8.07%. The firm’s revenue for the quarter was up 11.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $4.64 EPS. On average, equities analysts expect that HCA Healthcare, Inc. will post 20.49 earnings per share for the current fiscal year.

HCA Healthcare announced that its board has authorized a stock repurchase program on Tuesday, January 30th that allows the company to buyback $6.00 billion in shares. This buyback authorization allows the company to repurchase up to 7.4% of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s board of directors believes its shares are undervalued.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 29th. Shareholders of record on Friday, March 15th were issued a dividend of $0.66 per share. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.60. The ex-dividend date was Thursday, March 14th. This represents a $2.64 annualized dividend and a yield of 0.82%. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.91%.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. Sanford C. Bernstein downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating and upped their target price for the company from $277.00 to $301.00 in a research report on Thursday, January 4th. Raymond James upped their target price on shares of HCA Healthcare from $300.00 to $330.00 and gave the company an “outperform” rating in a research report on Wednesday, January 31st. Wells Fargo & Company upped their price objective on HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a report on Thursday, March 28th. Royal Bank of Canada upped their price target on HCA Healthcare from $308.00 to $322.00 and gave the company an “outperform” rating in a research note on Wednesday, January 31st. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $335.00 target price on shares of HCA Healthcare in a research note on Wednesday, April 10th. Four equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $314.05.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.